I've spent my career turning challenges in triumphs across healthcare. Now I'm the COO of Pendant, the first Accountable Care Model in fertility benefits, delivering value for dollars in family building.
I started as a biomedical engineer at Duke — with the goal of working inside systems that affect people's lives and health. That thread has run through everything since.
My first role out of school took me into healthcare operations. In 2016, I joined SmithRx as employee #1 — hired to build a pharmacy benefit manager from scratch. Over nearly five years, I built the strategy, operations, pricing, and customer success functions that took the company from concept to scale.
From there, I went deeper into women's health. I spent almost five years at Kindbody, one of the leading women's fertility and health companies in the country — rising to EVP of Strategic Business Lines, where I led KindRx, KindLabs, KindMan, and KindEOS.
In 2026, I joined the founding team of Pendant Health as COO. Pendant is building a new kind of women's health and fertility benefits company — one designed for clarity, accountability, and real outcomes.
The through-line in all of it: women's health is where the gaps are biggest, the complexity is highest, and the opportunity to actually change outcomes is most real. That's where I want to be.
Designing employer fertility benefits that deliver real outcomes — across every path to parenthood, not just IVF.
How pharmacy benefit management works, where it breaks down, and what aligned PBM models actually look like in practice.
The mechanics of drug pricing, transparency, and what employers can do to stop paying for opacity they don't have to accept.
Building the operational infrastructure behind benefits — implementation, vendor management, outcomes measurement, and what good actually looks like at scale.
"Women's health has been underfunded, under-researched, and under-led for too long. I'm working to change all three — by reshaping how employers invest in women's health, and by putting more women in the leadership roles that decide what that investment looks like."— Sydni Meyrowitz
BSE, Biomedical Engineering
Private network driving more women into positions of power and keeping them there.
The story of Ernest Shackleton's 1914 Antarctic expedition. The Shackleton family motto — Fortitudine Vincimus, "by endurance we conquer" — has become a personal north star: a reminder that the most meaningful work rarely goes as planned, and that endurance is a strategy.
IVF global market dynamics & reimbursement policy. Value in Health, Vol. 16.
Joined the founding team to build a new kind of women's health and fertility benefits company — one designed to deliver better outcomes, greater flexibility, and a more accountable experience for employers and members. Pendant connects how fertility benefits are managed: member-first experience, transparent pricing, better data.
Strategic advisor to MonCap, the investment firm backing Pendant, as the company moved from concept to launch.
Nearly five years at one of the country's leading women's fertility and health companies. Rose from SVP of Pharmacy Strategy & Operations to EVP of Strategic Business Lines, leading KindRx, KindLabs, KindMan, and KindEOS — spanning pharmacy, lab, and men's health across the Kindbody ecosystem.
Hired as employee #1 to build an innovative pharmacy benefit manager (PBM) aimed at improving patient lives through a uniquely aligned business model. Led strategy, GTM/pricing, network management, implementation, plan operations, customer success, member support, and clinical services.
Reproductive health is unlike any other therapeutic area because reimbursement alone is insufficient to assess opportunity. This paper examines the impact of cultural trends, medical tourism, declining birth rates, increasing IVF access, and reforms to public policy — and what manufacturers and policymakers should understand about evolving market access environments globally.
A study of the French National Health Authority examining whether pharmaceutical manufacturers are increasingly targeting smaller oncology patient populations and the implications for market access, pricing, and reimbursement strategy.
Women are 51% of the population and nearly 80% of household healthcare decisions. Yet the average employer still treats women's health as a line item. That's a business strategy failure.
For years I waited to be invited to the table. The shift came when I realized the invitation was never coming — and that was actually good news.
Not all fertility benefits are created equal. The difference between IVF coverage and actual fertility benefits is costing employees thousands — and costing employers credibility.
We tell women to find mentors. We rarely tell them to find sponsors. Here's the difference — and why it's the key driver of the leadership gap.
Women's health finally had a seat at the table at JPM this year — not a side event, not a niche panel, but part of the core dialogue. Here's what it means.
Women are the majority of healthcare consumers. The decisions made in the rooms they're not in shape what care looks like for millions. That has to change.